Maxion is applying its patented KnotBody technology to generate potent, selective, and long-acting antibody-like drugs.

KnotBody technology combines the benefits of naturally occurring mini-proteins, which have ion channel modulating activity, with antibodies, using phage and mammalian display technologies.